R. Mondéjar
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies, Inflammatory Biomarkers in Disease Prognosis, T-cell and Retrovirus Studies
Most-Cited Works
- → Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients(2019)257 cited
- → Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations(2017)69 cited
- → Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers(2021)50 cited
- → Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways(2019)49 cited
- → Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines(2021)48 cited
- → MRI findings in a remitting-relapsing case of Bickerstaff encephalitis(2002)38 cited
- → Mutation Prevalence of Cerebral Cavernous Malformation Genes in Spanish Patients(2014)36 cited
- → Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome(2014)33 cited
- → Clinical and Molecular Study of the Extracellular Matrix Protein 1 Gene in a Spanish Family with Lipoid Proteinosis(2014)17 cited
- → Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumors(2016)14 cited